Sricharan Reddy Varra

Sricharan Reddy Varra

Auto-generated profile, based on publicly available information

Sricharan Reddy Varra

Department of Pathology, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CLCandace C. Liu
Candace C. Liu
NGNoah F. Greenwald
Noah F. Greenwald
AKAlex Kong
Alex Kong
EMErin F. McCaffrey
Erin F. McCaffrey
KLKe Xuan Leow
Ke Xuan Leow
MAMichael Angelo
Michael Angelo
While technologies for multiplexed imaging have provided an unprecedented understanding of tissue composition in health and disease, interpreting this data remains a significant computational challenge. To understand the spatial organization of tissue and how it relates to disease processes, imaging studies typically focus on cell-level phenotypes. However, images can capture biologically important objects that are outside of cells, such as the extracellular matrix. Here, we describe a pipeline, Pixie, that achieves robust and quantitative annotation of pixel-level features using unsupervised clustering and show its application across a variety of biological contexts and multiplexed imaging platforms. Furthermore, current cell phenotyping strategies that rely on unsupervised clustering can be labor intensive and require large amounts of manual cluster adjustments. We demonstrate how pixel clusters that lie within cells can be used to improve cell annotations. We comprehensively evaluate pre-processing steps and parameter choices to optimize clustering performance and quantify the reproducibility of our method. Importantly, Pixie is open source and easily customizable through a user-friendly interface.

8 October 2025 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JRJosef Lorenz Rumberger
Josef Lorenz Rumberger
NGNoah F. Greenwald
Noah F. Greenwald
JRJolene S. Ranek
Jolene S. Ranek
PBPotchara Boonrat
Potchara Boonrat
CWCameron Walker
Cameron Walker
MAMichael Angelo
Michael Angelo

18 February 2026 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
NGNoah F. Greenwald
Noah F. Greenwald
INIris Nederlof
Iris Nederlof
CSCameron Sowers
Cameron Sowers
DDDaisy Yi Ding
Daisy Yi Ding
SPSeongyeol Park
Seongyeol Park
MAMichael Angelo
Michael Angelo

2 June 2026 in Cancer Research
Verified
Journal Article
Open access
AKAbhishek Koladiya
Abhishek Koladiya
ZGZinaida Good
Zinaida Good
SVSricharan Reddy Varra
Sricharan Reddy Varra
PDPablo Domizi
Pablo Domizi
SBSean C. Bendall
Sean C. Bendall
KDKara L. Davis
Kara L. Davis
Analysis of tumors using single-cell and spatial modalities is critical to advance our understanding of cancer. The growth of technologies that enable these studies provides an increasing number of single cell datasets. Integrating such data across studies will increase the impact of individual studies and speed cancer research. Most existing integration approaches are tailored to transcriptomic data and assume large sets of shared features, an assumption that fails for lower dimensional proteomic measurements. Here, we developed CellFuse, a deep learning–based integration framework that unifies antibody-based proteomic datasets, including high-dimensional cytometry, cellular indexing of transcriptomes and epitopes by sequencing, and spatial proteomics data. Leveraging supervised contrastive learning, CellFuse learned a shared embedding space that enabled accurate cross-modality cell-type prediction and robust label transfer across tumor samples and experimental conditions. Applied to datasets spanning peripheral blood, bone marrow, and lymphoma, CellFuse consistently outperformed existing approaches in recovering clinically relevant populations, including rare malignant and immune subsets. In solid tumors, it reconstructed spatially resolved microenvironments, capturing interactions between malignant, stromal, and immune cells that correlated with treatment response. By enabling scalable, modality-agnostic integration, CellFuse provides a powerful tool to uncover prognostic cell states and delineate the architecture of the tumor–immune ecosystem with translational relevance, driving cancer discoveries. Significance: CellFuse is a supervised contrastive learning framework enabling accurate, scalable integration of single-cell proteomic and transcriptomic data, overcoming sparse marker overlap and differing distributions to improve analysis of single-cell data in cancer.